KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Short-Term Debt issuances (2021 - 2025)

Elanco Animal Health's Short-Term Debt issuances history spans 5 years, with the latest figure at $125.0 million for Q1 2025.

  • For Q1 2025, Short-Term Debt issuances rose 150.0% year-over-year to $125.0 million; the TTM value through Dec 2025 reached $125.0 million, up 150.0%, while the annual FY2025 figure was $125.0 million, 150.0% up from the prior year.
  • Short-Term Debt issuances for Q1 2025 was $125.0 million at Elanco Animal Health, up from -$120.0 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $500.0 million in Q2 2022 and bottomed at -$563.0 million in Q4 2022.
  • The 5-year median for Short-Term Debt issuances is $81.5 million (2022), against an average of $14.6 million.
  • The largest annual shift saw Short-Term Debt issuances skyrocketed 217.46% in 2023 before it tumbled 220.0% in 2024.
  • A 5-year view of Short-Term Debt issuances shows it stood at -$500.0 million in 2021, then decreased by 12.6% to -$563.0 million in 2022, then soared by 117.76% to $100.0 million in 2023, then crashed by 220.0% to -$120.0 million in 2024, then skyrocketed by 204.17% to $125.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Short-Term Debt issuances are $125.0 million (Q1 2025), -$120.0 million (Q4 2024), and $120.0 million (Q2 2024).